Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: Clinical case series and review of the literature
- PMID: 32729194
- DOI: 10.1002/pbc.28621
Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: Clinical case series and review of the literature
Abstract
Sertoli-Leydig cell tumors (SLCTs) are rare ovarian neoplasms in pediatric patients. More exceedingly rare are SLCTs that also contain heterologous rhabdomyosarcoma (RMS) elements. For these patients, there is no standardized treatment. We report four cases of pediatric SLCT with heterologous RMS elements that were successfully treated with surgical resection and adjuvant chemotherapy. All four patients are alive and remain in remission.
Keywords: Sertoli-Leydig cell tumor; heterologous elements; rhabdomyosarcoma.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Schultz KA, Schneider DT, Pashankar F, Ross J, Frazier L. Management of ovarian and testicular sex cord-stromal tumors in children and adolescents. J Pediatr Hematol Oncol. 2012;34(Suppl 2):S55-S63.
-
- Tandon R, Goel P, Saha PK, Takkar N, Punia RP. A rare ovarian tumor - Sertoli-Leydig cell tumor with heterologous element. MedGenMed. 2007;9(4):44.
-
- Schneider DT, Orbach D, Cecchetto G, et al. Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT). Eur J Cancer. 2015;51(4):543-550.
-
- Al-Hussaini M, Al-Othman Y, Hijazi E, McCluggage WG. A report of ovarian Sertoli-Leydig cell tumors with heterologous intestinal-type glands and alpha fetoprotein elevation and review of the literature. Int J Gynecol Pathol. 2018;37(3):275-283.
-
- Yamamoto S, Sakai Y. Ovarian Sertoli-Leydig cell tumor with heterologous hepatocytes and a hepatocellular carcinomatous element. Int J Gynecol Pathol. 2019;38(3):247-252.
Publication types
MeSH terms
LinkOut - more resources
Medical